Pharma-Bio Serv, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q2 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q2 2016 to Q2 2024.
  • Pharma-Bio Serv, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending July 31, 2024 was $0.000.
  • Pharma-Bio Serv, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the twelve months ending July 31, 2024 was $0.000.
  • Pharma-Bio Serv, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $0.000.
  • Pharma-Bio Serv, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $0.000, a 100% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $1.4K, a 63.7% decline from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Trailing 12 Months (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 $0 May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $0 $0 $0 Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $0 $0 $0 Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $0 $0 $0 Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $0 $0 $0 May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 $0 $0 $0 Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $0 $0 $0 Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $0 $0 $0 Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 $0 $0 $0 May 1, 2022 Jul 31, 2022 10-Q 2022-09-14
Q1 2022 $0 $0 -$552 -100% Feb 1, 2022 Apr 30, 2022 10-Q 2022-06-14
Q4 2021 $552 $0 -$852 -100% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 $1.4K $0 -$914 -100% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 $2.32K $0 -$951 -100% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $3.27K $552 -$436 -44.1% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $3.71K $852 -$164 -16.1% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $3.87K $914 -$148 -13.9% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 $4.02K $951 -$145 -13.2% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $4.16K $988 -$437 -30.7% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $4.6K $1.02K +$537 +112% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q3 2019 $4.06K $1.06K +$1.17K Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 $2.89K $1.1K +$577 +111% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $2.31K $1.43K +$876 +160% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 $1.44K $479 -$63 -11.6% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $1.5K -$112 +$663 +85.5% Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 $835 $519 -$8 -1.52% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 $843 $549 -$2.01K -78.5% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 $2.85K $542 -$93 -14.6% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 $2.95K -$775 Aug 1, 2017 Oct 31, 2017 10-K 2019-01-29
Q2 2017 $527 -$167 -24.1% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $2.56K Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
Q4 2016 $635 Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q2 2016 $694 May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.